Studi In Silico Senyawa Bioaktif Kopi Arabika (Coffea Arabica) Sebagai Kandidat Antikanker terhadap Reseptor PI3K p110-delta subunit

Fitria Melani, Silvi Ayudiah Putri, Anis Zulnita, Madyawati Latief, Sustrisno Sutrisno, Indra Lasmana Tarigan

Abstract


Each year, 9.6 million people lose their lives to cancer, making it the world's second worst killer. Cancer is a disorder that results from genetic changes and has abnormal growth and spreads to other parts of the body. Cancer treatment is currently done with chemotherapy which has unfavorable side effects, so research needs to be done to determine safer alternatives to cancer treatment. This study aims to determine the activity of bioactive compounds in Arabica coffee beans that have potential as anticancer through identification of target receptors and interaction studies using molecular docking methods against PI3K p110-delta subunit receptors. The results showed that of the 21 compounds, five compounds gave good results, namely compounds 4-O-feruloylqunic acid, 4-O-caffeoylqunic acid, gluconic acid, 3-O-feruloylqunic acid and 3-O-caffeoylqunic acid with bond energy (ΔG) and inhibition constant values of -5.47; -5.33; -4.73; -4.69; -4.40 kcal/mol and 98.02; 123.62; 340.97; 363.82; 591.97 μM, respectively. So that these test ligands/compounds can have potential as PI3K receptor inhibitors in cancer treatment

Keywords


Antikanker; Docking; Kopi Arabika; PI3K

Full Text:

PDF

References


A. Fadlan, T. Warsito, and S. Sarmoko, “Studi In Silico Potensi Antikanker Senyawa Kaempferida,” Alchemy, vol.
10, no. 1, pp. 14–21, 2022, doi: 10.18860/al.v10i1.13317.
[2] C. Q. da Silva et al., “Risk assessment of coffees of different qualities and degrees of roasting,” Food Res. Int., vol.
141, no. January, 2021, doi: 10.1016/j.foodres.2020.110089.
[3] J. S. Jeon et al., “Determination of chlorogenic acids and caffeine in homemade brewed coffee prepared under
various conditions,” J. Chromatogr. B Anal. Technol. Biomed. Life Sci., vol. 1064, no. August, pp. 115–123, 2017,
doi: 10.1016/j.jchromb.2017.08.041.
[4] H. Husniati, M. Y. Sari, and A. Sari, “Kajian : Karakterisasi Senyawa Aktif Asam Klorogenat Dalam Kopi Robusta
SebaHusniati, H., Sari, M. Y., & Sari, A. (2021). Kajian : Karakterisasi Senyawa Aktif Asam Klorogenat Dalam Kopi
Robusta Sebagai Antioksidan Review : Characterization of active compo,” Teknol. Argo Ind., vol. 12, no. 2, pp. 34–
39, 2021.
[5] A. Priftis et al., “Comparison of antioxidant activity between green and roasted coffee beans using molecular
methods,” Mol. Med. Rep., vol. 12, no. 5, pp. 7293–7302, 2015, doi: 10.3892/mmr.2015.4377.
[6] K. Belguidoum, H. Amira-Guebailia, Y. Boulmokh, and O. Houache, “HPLC coupled to UV-vis detection for
quantitative determination of phenolic compounds and caffeine in different brands of coffee in the Algerian
market,” J. Taiwan Inst. Chem. Eng., vol. 45, no. 4, pp. 1314–1320, 2014, doi: 10.1016/j.jtice.2014.03.014.
[7] B. E. Mojica et al., “The Impact of the Roast Levels of Coffee Extracts on their Potential Anticancer Activities,” J.
Food Sci., vol. 83, no. 4, pp. 1125–1130, 2018, doi: 10.1111/1750-3841.14102.
[8] F. Piacente, I. Caffa, and A. Nencioni, “Nicotinic acid: A case for a vitamin that moonlights for cancer?,” Cell Cycle,
vol. 16, no. 18, pp. 1635–1636, 2017, doi: 10.1080/15384101.2017.1360633.
[9] M. K. Chahar, N. Sharma, M. P. Dobhal, and Y. C. Joshi, “Flavonoids: A versatile source of anticancer drugs,”
Pharmacogn. Rev., vol. 5, no. 9, pp. 1–12, 2011, doi: 10.4103/0973-7847.79093.
[10] M. Yusuf and R. Alyidrus, “Uji Antiangiogenesis Secara In Vivo Ekstrak Etanol Biji Kopi Robusta (Coffea Robusta)
dengan Metode Chorio Allantoic Membrane (CAM),” J. Farm. Galen. (Galenika J. Pharmacy), vol. 6, no. 1, pp. 63–
69, 2020, doi: 10.22487/j24428744.2020.v6.i1.14975.
[11] S. Safe, J. Kothari, A. Hailemariam, S. Upadhyay, L. A. Davidson, and R. S. Chapkin, “Health Benefits of Coffee
Consumption for Cancer and Other Diseases and Mechanisms of Action,” Int. J. Mol. Sci., vol. 24, no. 3, 2023, doi:
10.3390/ijms24032706.
[12] T. Makino et al., “Anti-proliferative and anti-migratory properties of coffee diterpenes kahweol acetate and cafestol
in human renal cancer cells,” Sci. Rep., vol. 11, no. 1, pp. 1–10, 2021, doi: 10.1038/s41598-020-80302-4.
[13] J. Montenegro et al., “Bioactive compounds, antioxidant activity and antiproliferative effects in prostate cancer cells
of green and roasted coffee extracts obtained by microwave-assisted extraction (MAE),” Food Res. Int., vol. 140,
no. 1, pp. 1–12, 2021.
[14] M. Funakoshi-Tago, K. Tago, C. Li, S. Hokimoto, and H. Tamura, Coffee decoction enhances tamoxifen
proapoptotic activity on MCF-7 cells, vol. 10, no. 1. Nature Publishing Group UK, 2020. doi: 10.1038/s41598-020-
76445-z.
[15] J. Zhu et al., “Associations of coffee and tea consumption with lung cancer risk,” Int. J. Cancer, vol. 148, no. 10,
pp. 2457–2470, 2021, doi: 10.1002/ijc.33445.
[16] M. Fox, H. R. Mott, and D. Owen, “Class IA PI3K regulatory subunits: p110-independent roles and structures,”
Biochem. Soc. Trans., vol. 48, no. 4, pp. 1397–1417, 2020, doi: 10.1042/BST20190845.
[17] Y. Huang, Y. Q. Xu, S. Y. Feng, X. Zhang, and J. D. Ni, “LncRNA TDRG1 promotes proliferation, invasion and epithelial-mesenchymal transformation of osteosarcoma through PI3K/AKT signal pathway,” Cancer Manag. Res.,
vol. 12, pp. 4531–4540, 2020, doi: 10.2147/CMAR.S248964.
[18] Adriani, “Prediksi Senyawa Bioaktif dari Tanaman Sanrego (Lunasia amara Blanco) Sebagai Inhibitor Enzim
Siklooksigenase-2 (COX-2) Melalui Pendekatan Molecular Docking,” J. Ilm. Pena, vol. 1, no. 1, pp. 6–11, 2018.
[19] B. Nemzer, N. Abshiru, and F. Al-Taher, “Identification of Phytochemical Compounds in Coffea arabica Whole
Coffee Cherries and Their Extracts by LC-MS/MS,” J. Agric. Food Chem., vol. 69, no. 11, pp. 3430–3438, 2021,
doi: 10.1021/acs.jafc.0c05937.
[20] D. J. Sen, K. Nandi, and D. Saha, “Rule of Five: The Five Men Army to Cross The Blood Brain Barrier for
Therapeutically Potent,” World J. Adv. Healthc. Res., vol. 5, no. 3, pp. 206–211, 2021, [Online]. Available:
https://www.researchgate.net/publication/351945081
[21] G. Syahputra, L. Ambarsari, and T. Sumaryada, “Simulasi Docking Kurkumin Enol, Bisdemetoksikurkumin dan
Analognya sebagai Inhibitor Enzim 12-Lipoksigenase,” J. Biofisika, vol. 10, no. 1, pp. 55–67, 2014.
[22] A. A. Elaine, A. Nisa, N. Tahara, D. Q. Aini, and Z. Syahriar, “Indonesian Journal of Biological Pharmacy In Silico
Study of Mangosteen Fruit (Garcinia mangostana L.) as Pancreatic Anticancer Against AKT Kinase,” Indones. J.
Biol. Pharm., vol. 3, no. 1, pp. 19–32, 2023, [Online]. Available: https://jurnal.unpad.ac.id/ijbp
[23] A. B. Pratama, R. Herowati, and H. M. Ansory, “Studi Docking Molekuler Senyawa Dalam Minyak Atsiri Pala
(Myristica fragrans H.) Dan Senyawa Turunan Miristisin Terhadap Target Terapi Kanker Kulit,” Maj. Farm., vol. 17,
no. 2, p. 233, 2021, doi: 10.22146/farmaseutik.v17i2.59297.
[24] K. K. Brown and A. Toker, “The phosphoinositide 3-kinase pathway and therapy resistance in cancer,”
F1000Prime Rep., vol. 7, no. February, pp. 1–8, 2015, doi: 10.12703/P7-13.
[25] A. Akinleye, P. Avvaru, M. Furqan, Y. Song, and D. Liu, “Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer
therapeutics,” J. Hematol. Oncol., vol. 6, no. 1, pp. 1–17, 2013, doi: 10.1186/1756-8722-6-88.
[26] Arwansyah, L. Ambarsari, and T. I. Sumaryada, “Simulasi Docking Senyawa Kurkumin Dan Analognya Sebagai
Inhibitor Enzim 12-Lipoksigenase,” Curr. Biochem., vol. 1, no. 1, pp. 11–19, 2014.
[27] O. Nursanti, “Docking Dan Uji Toksisitas Secara Insilico Untuk Mendapatkan Kandidat Obat Analgesik,”
INPHARNMED J. (Indonesian Pharm. Nat. Med. Journal), vol. 6, no. 1, p. 35, 2022, doi:
10.21927/inpharnmed.v6i1.1922.
[28] X. Du et al., “Insights into protein–ligand interactions: Mechanisms, models, and methods,” Int. J. Mol. Sci., vol. 17,
no. 2, pp. 1–34, 2016, doi: 10.3390/ijms17020144.
[29] M. Umamaheswari, A. Madeswaran, and K. Asokkumar, “Virtual screening analysis and in-vitro xanthine oxidase
inhibitory activity of some commercially available flavonoids,” Iran. J. Pharm. Res., vol. 12, no. 3, pp. 317–323,
2013.
[30] I. W. Sari, J. Junaidin, and D. Pratiwi, “Studi Molecular Docking Senyawa Flavonoid Herba Kumis Kucing
(Orthosiphon stamineus B.) Pada Reseptor Α-Glukosidase Sebagai Antidiabetes Tipe 2,” J. Farmagazine, vol. 7,
no. 2, p. 54, 2020, doi: 10.47653/farm.v7i2.194.
[31] N. Kurnyawaty, H. Suwito, and F. Kusumattaqiin, “Studi In Silico Potensi Aktivitas Farmakologi Senyawa Golongan
Dihidrotetrazolopirimidin,” J. Kim. (JOURNAL Chem., vol. 15, no. 2, pp. 172–179, 2021.




DOI: https://doi.org/10.18860/al.v13i1.28636

Refbacks

  • There are currently no refbacks.


Copyright (c) 2025 Fitria Melani, Silvi Ayudiah Putri, Anis Zulnita, Madyawati Latief, Indra Lasmana Tarigan

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Kirim NME Creative Commons

This work is licensed under NME Creative Commons Atribusi-NonKomersial-BerbagiSerupa 4.0 Internasional.
ALCHEMY is managed by  http://kimia.uin-malang.ac.id/
© All rights reserved 2016. Alchemy, Journal of Chemistry, eISSN 2460-6871

 

View My Stats